Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 15, 2020 - Issue
Submit an article Journal homepage
146
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Alpha-1 Antitrypsin Augmentation Therapy Improves Survival in Severely Deficient Patients with Predicted FEV1 Between 10% and 60%: A Retrospective Analysis of the NHLBI Alpha-1 Antitrypsin Deficiency Registry

Franck F Rahaghi1 Department of Pulmonary and Critical Care, Cleveland Clinic Florida, Weston, FL, USACorrespondence[email protected]
,
Richard Monk2 Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Medical University of South Carolina, Charleston, SC, USA
,
Viswanathan Ramakrishnan3 Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC, USA
,
Tatsiana Beiko2 Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Medical University of South Carolina, Charleston, SC, USA
&
Charlie Strange2 Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Medical University of South Carolina, Charleston, SC, USAORCID Iconhttps://orcid.org/0000-0002-8109-8067
ORCID Icon
Pages 3193-3199 | Published online: 03 Dec 2020

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

João Cardoso, António Jorge Ferreira, Miguel Guimarães, Ana Sofia Oliveira, Paula Simão & Maria Sucena. (2021) Treatable Traits in COPD – A Proposed Approach. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 3167-3182.
Read now
Felix J F Herth, Robert A Sandhaus, Alice M Turner, Maria Sucena, Tobias Welte & Timm Greulich. (2021) Alpha 1 Antitrypsin Therapy in Patients with Alpha 1 Antitrypsin Deficiency: Perspectives from a Registry Study and Practical Considerations for Self-Administration During the COVID-19 Pandemic. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 2983-2996.
Read now

Articles from other publishers (4)

Tobias Meischl, Karin Schmid-Scherzer, Florian Vafai-Tabrizi, Gert Wurzinger, Eva Traunmüller-Wurm, Kristina Kutics, Markus Rauter, Fikreta Grabcanovic-Musija, Simona Müller, Norbert Kaufmann, Judith Löffler-Ragg, Arschang Valipour & Georg-Christian Funk. (2023) The impact of diagnostic delay on survival in alpha-1-antitrypsin deficiency: results from the Austrian Alpha-1 Lung Registry. Respiratory Research 24:1.
Crossref
J.-F. Mornex. (2022) Le déficit en alpha 1-antitrypsine. Revue des Maladies Respiratoires 39:8, pages 698-707.
Crossref
J.-F. Mornex, M. Balduyck, M. Bouchecareilh, A. Cuvelier, R. Epaud, M. Kerjouan, O. Le Rouzic, C. Pison, L. Plantier, M.-C. Pujazon, M. Reynaud-Gaubert, A. Toutain, B. Trumbic, M.-C. Willemin, M. Zysman, O. Brun, M. Campana, F. Chabot, V. Chamouard, M. Dechomet, J. Fauve, B. Girerd, C. Gnakamene, S. Lefrançois, J.-N. Lombard, B. Maitre, C. Maynié-François, A. Moerman, A. Payancé, P. Reix, D. Revel, M.-P. Revel, M. Schuers, P. Terrioux, D. Theron, F. Willersinn, V. Cottin & H. Mal. (2022) Atteinte pulmonaire du déficit en alpha-1 antitrypsine. Recommandations pratiques pour le diagnostic et la prise en charge. Revue des Maladies Respiratoires 39:7, pages 633-656.
Crossref
Khushboo Goel, Charlie Strange, Robert A Sandhaus, Irina Petrache & Karina A Serban. (2021) Updates in the Management of Alpha-1 Antitrypsin Deficiency Lung Disease. US Respiratory & Pulmonary Diseases 6:1, pages 26.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.